Pharmacokinetic and pharmacodynamic basis for overcoming acetaldehyde-induced adverse reaction in Asian alcoholics, heterozygous for the variant ALDH2*2 gene allele
- PMID: 19584771
- DOI: 10.1097/FPC.0b013e32832ecf2e
Pharmacokinetic and pharmacodynamic basis for overcoming acetaldehyde-induced adverse reaction in Asian alcoholics, heterozygous for the variant ALDH2*2 gene allele
Abstract
Objectives: It has been well documented that although homozygosity of the variant aldehyde dehydrogenese-2 (ALDH2) gene allele, ALDH2*2, in Asians almost fully protects against alcoholism, the heterozygosity only affords a partial protection to varying degrees. The partial protection against alcoholism has been ascribed to the faster elimination of acetaldehyde by residual hepatic ALDH2 activity and the lower accumulation in circulation in nonalcoholic heterozygotes. The physiological basis for overcoming the protection in ALDH2*1/*2 alcoholics, however, remains unclear.
Methods: To address this question, we recruited a total of 27 Han Chinese alcohol-dependent men, matched by age and body mass index, controlled for normal liver and cardiovascular functions, from a population base of 221 alcoholics. The participants were divided into ALDH2*1/*1 homozygotes (n = 13) and ALDH2*1/*2 heterozygotes (n = 14). After a moderate dose of ethanol (0.5 g/kg body weight), blood ethanol/acetaldehyde/acetate concentrations, cardiac and extracranial/intracranial arterial hemodynamic parameters, as well as self-rated subjective sensations, were measured for 130 min.
Results: ALDH2*1/*2 alcoholics exhibited significantly higher blood acetaldehyde levels as well as prominent cardiovascular effects and the subjective perceptions, compared with the ALDH2*1/*1 alcoholics. Comparable profiles of blood acetaldehyde were found between heterozygotic alcoholics and the previously reported nonalcoholic heterozygotes intaking the same dose of ethanol. ALDH2*1/*2 alcoholics revealed, however, significantly lower intensities in both physiologic and psychologic responses than did the nonalcoholic heterozygotes.
Conclusion: These results indicate that acetaldehyde, rather than ethanol or acetate, is primarily responsible for the observed alcohol sensitivity reactions in heterozygotic alcoholics and suggest that physiological tolerance and/or innate low sensitivity may play a crucial role in overcoming the deterring response. A potential pharmacogenetic classification of acetaldehydism and alcoholism for alcoholics carrying the different ALDH2 genotypes is proposed.
Similar articles
-
Pharmacokinetic and pharmacodynamic basis for partial protection against alcoholism in Asians, heterozygous for the variant ALDH2*2 gene allele.Pharmacogenet Genomics. 2007 Oct;17(10):845-55. doi: 10.1097/FPC.0b013e3282609e67. Pharmacogenet Genomics. 2007. PMID: 17885622 Clinical Trial.
-
Involvement of acetaldehyde for full protection against alcoholism by homozygosity of the variant allele of mitochondrial aldehyde dehydrogenase gene in Asians.Pharmacogenetics. 1999 Aug;9(4):463-76. Pharmacogenetics. 1999. PMID: 10780266
-
Alcohol metabolism and cardiovascular response in an alcoholic patient homozygous for the ALDH2*2 variant gene allele.Alcohol Clin Exp Res. 1999 Dec;23(12):1853-60. Alcohol Clin Exp Res. 1999. PMID: 10630602
-
Polymorphism of ethanol-metabolism genes and alcoholism: correlation of allelic variations with the pharmacokinetic and pharmacodynamic consequences.Chem Biol Interact. 2009 Mar 16;178(1-3):2-7. doi: 10.1016/j.cbi.2008.10.029. Epub 2008 Oct 30. Chem Biol Interact. 2009. PMID: 19014920 Review.
-
Alcohol and aldehyde dehydrogenase polymorphisms and alcoholism.Behav Genet. 1993 Mar;23(2):131-6. doi: 10.1007/BF01067417. Behav Genet. 1993. PMID: 8512527 Review.
Cited by
-
Pharmacological recruitment of aldehyde dehydrogenase 3A1 (ALDH3A1) to assist ALDH2 in acetaldehyde and ethanol metabolism in vivo.Proc Natl Acad Sci U S A. 2015 Mar 10;112(10):3074-9. doi: 10.1073/pnas.1414657112. Epub 2015 Feb 23. Proc Natl Acad Sci U S A. 2015. PMID: 25713355 Free PMC article.
-
Association Between ALDH2 Polymorphisms and the Risk of Diabetes Mellitus in Hypertensive Patients.Int J Gen Med. 2023 Dec 6;16:5719-5727. doi: 10.2147/IJGM.S435598. eCollection 2023. Int J Gen Med. 2023. PMID: 38084269 Free PMC article.
-
Alterations in tryptophan metabolism and de novo NAD+ biosynthesis within the microbiota-gut-brain axis in chronic intestinal inflammation.Front Med (Lausanne). 2024 Jul 2;11:1379335. doi: 10.3389/fmed.2024.1379335. eCollection 2024. Front Med (Lausanne). 2024. PMID: 39015786 Free PMC article.
-
Systemic Adeno-Associated Virus-Mediated Gene Therapy Prevents the Multiorgan Disorders Associated with Aldehyde Dehydrogenase 2 Deficiency and Chronic Ethanol Ingestion.Hum Gene Ther. 2020 Feb;31(3-4):163-182. doi: 10.1089/hum.2019.268. Epub 2020 Jan 28. Hum Gene Ther. 2020. PMID: 31801381 Free PMC article.
-
Aldehyde Dehydrogenase 2 rs671 Polymorphism is Associated with Susceptibility of Coronary Atherosclerosis in Patients with Hypertension.Int J Gen Med. 2025 Feb 10;18:681-690. doi: 10.2147/IJGM.S501396. eCollection 2025. Int J Gen Med. 2025. PMID: 39959460 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous